MONTREAL, May 6 /PRNewswire-FirstCall/ - DRAXIS Health Inc. (TSX: DAX)(Nasdaq: DRAX) will report financial and operating results for its FirstQuarter 2008 on Friday May 9, 2008.
Annual and Special Meeting of Shareholders
The annual and special meeting (the 'Meeting') of shareholders of DRAXISis scheduled to be held at the offices of McCarthy Tetrault LLP, Suite 5300,TD Bank Tower, Toronto, Ontario, Canada on Friday, May 23, 2008 at 10:00 a.m.(Toronto time).
At the Meeting, shareholders will be asked to approve a plan ofarrangement under the Canada Business Corporations Act, involving DRAXIS, itsshareholders and Jubilant Acquisition Inc. (the 'Purchaser'), an indirectwholly-owned subsidiary of Jubilant Organosys Ltd. The plan of arrangementwill result in the acquisition by the Purchaser of all the outstanding commonshares of DRAXIS for a consideration of U.S.$6.00 per common share.
The Notice of Annual and Special Meeting and Management InformationCircular relating to the Meeting has been filed with Canadian and U.S.securities regulators and has been mailed to DRAXIS shareholders and isavailable at www.sedar.com and www.sec.gov, as well as on DRAXIS' website atwww.draxis.com. The Circular provides important information about the proposedplan of arrangement, as well as important information regarding votingprocedures. All shareholders are urged to read the Circular.
About DRAXIS Health Inc.
DRAXIS Health, through its wholly owned operating subsidiary, DRAXISSpecialty Pharmaceuticals Inc., provides products in three categories: sterileproducts, non-sterile products and radiopharmaceuticals. Sterile productsinclude liquid and freeze-dried (lyophilized) injectables plus sterileointments and creams. Non-sterile products are produced as solid oral andsemi-solid dosage forms. Radiopharmaceuticals are used for both therapeuticand diagnostic molecular imaging applications. Pharmaceutical contractmanufacturing services are provided through the DRAXIS Pharma division andradiopharmaceuticals are developed, produced, and sold through the DRAXIMAGEdivision.
